Catalyst Funds Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,900	Closed	-$43.2K	–	1256
2024 Q3	$43.2K	Sell	1,900 -3,100	-62%	-$70.5K	0.01%	854
2024 Q2	$65.1K	Buy	5,000 +2,300	+85%	+$29.9K	0.02%	369
2024 Q1	$47.3K	Buy	+2,700	New	+$47.3K	0.01%	574